These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25600666)

  • 1. Implementation of the global risk analysis in pulsed-dose rate brachytherapy: methods and results.
    Mazeron R; Aguini N; Rivin Del Campo E; Dumas I; Gensse MC; Brusadin G; Lefkopoulos D; Deutsch E; Haie-Meder C
    Cancer Radiother; 2015 Apr; 19(2):89-97. PubMed ID: 25600666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving safety in radiotherapy: the implementation of the Global Risk Analysis method.
    Mazeron R; Aguini N; Rivin E; Baudré A; Bour MS; Dumas I; Hubert F; Lopes S; Desroches A; Deutsch E; Lefkopoulos D; Bourhis J
    Radiother Oncol; 2014 Aug; 112(2):205-11. PubMed ID: 25245555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving safety of preparation and administration of medicines and enteral nutrition in a neonatal care unit: Global risk analysis.
    Zribi K; Seydoux CL; Coatantiec Y; Chenet V; Karnycheff F; Sejean K; Vivet A; Migeon A; Aboulghit K; Ayoubi JM; Bonan B
    Ann Pharm Fr; 2020 Mar; 78(2):158-166. PubMed ID: 32037026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cartography and risk management in radiotherapy: A collaborative work of the department of radiotherapy and the department of quality and risk management at the Jean-Godinot Institute].
    Nguyen TD; Devie I; Heusghem M; Gaillot-Petit N; Loiseau M
    Cancer Radiother; 2010 Jan; 14(1):24-8. PubMed ID: 19969499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervix cancer brachytherapy: high dose rate.
    Miglierini P; Malhaire JP; Goasduff G; Miranda O; Pradier O
    Cancer Radiother; 2014 Oct; 18(5-6):452-7. PubMed ID: 25151650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety in brachytherapy].
    Marcié S; Marinello G; Peiffert D; Lartigau É
    Cancer Radiother; 2013 Apr; 17(2):166-9. PubMed ID: 23465784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
    Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
    Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulsed-dose rate brachytherapy in cervical cancers: why, how?].
    Mazeron R; Dumas I; Martin V; Martinetti F; Benhabib-Boukhelif W; Gensse MC; Chargari C; Guemnie-Tafo A; Haie-Méder C
    Cancer Radiother; 2014 Oct; 18(5-6):447-51. PubMed ID: 25155782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interest of the preliminary risk analysis method in a central sterile supply department.
    Niel-Lainé J; Martelli N; Bonan B; Talon D; Desroches A; Prognon P; Vincent F
    BMJ Qual Saf; 2011 Aug; 20(8):698-703. PubMed ID: 21385890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose rate in brachytherapy using after-loading machine: pulsed or high-dose rate?
    Hannoun-Lévi JM; Peiffert D
    Cancer Radiother; 2014 Oct; 18(5-6):437-40. PubMed ID: 25195117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of failure mode and effective analysis for high dose rate brachytherapy at Tata Memorial Hospital, Mumbai, India.
    Swamidas J; Khanna N; Mahantshetty U; Somesan V; Deshpande DD; Shrivastava SK
    Cancer Radiother; 2018 Jun; 22(4):334-340. PubMed ID: 29859762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints.
    Lang S; Kirisits C; Dimopoulos J; Georg D; Pötter R
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):619-27. PubMed ID: 17869676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system?
    Nickers P; Lenaerts E; Thissen B; Deneufbourg JM
    Radiother Oncol; 2005 Feb; 74(2):131-6. PubMed ID: 15734200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
    Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
    Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk analysis in radiation therapy: state of the art].
    Mazeron R; Aguini N; Deutsch É
    Cancer Radiother; 2013; 17(4):308-16, quiz 332. PubMed ID: 23787020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT-on-rails-guided HDR brachytherapy: single-room, rapid-workflow treatment delivery with integrated image guidance.
    Orcutt KP; Libby B; Handsfield LL; Moyer G; Showalter TN
    Future Oncol; 2014 Mar; 10(4):569-75. PubMed ID: 24754589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [End of the commercialisation of (192)Ir wires in France: proposals of the groupe de Curiethérapie de la SFRO].
    Peiffert D; Hannoun-Lévi JM; Oldrini S; Brunaud C
    Cancer Radiother; 2014 Oct; 18(5-6):441-6. PubMed ID: 25218567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-guided brachytherapy for cervical cancer: a Canadian Brachytherapy Group survey.
    Pavamani S; D'Souza DP; Portelance L; Craighead PS; Pearce AG; Traptow LL; Doll CM
    Brachytherapy; 2011; 10(5):345-51. PubMed ID: 21345744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor and normal tissue dosimetry changes during MR-guided pulsed-dose-rate (PDR) brachytherapy for cervical cancer.
    Morgia M; Cuartero J; Walsh L; Jezioranski J; Keeler K; Xie J; Massey C; Williamson D; Cho YB; Oh S; Fyles A; Milosevic M
    Radiother Oncol; 2013 Apr; 107(1):46-51. PubMed ID: 23540555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.